What Is Soft Tissue Sarcoma Symptoms Causes Treatment?

Soft tissue sarcoma is a rare cancer that starts in the tissues that connect, support, and surround other body structures. These tissues include fat, muscle, blood vessels, nerves, tendons, and the lining of joints. There are more than 50 different subtypes, and treatment depends heavily on the specific type, location, and stage of the tumor. Early diagnosis matters because these tumors can grow silently, and symptoms often appear only once the mass is large enough to press on nearby structures.

What Is Soft Tissue Sarcoma?

Soft tissue sarcoma is a malignant tumor that arises from mesenchymal cells, which are the cells that normally develop into fat, muscle, cartilage, and connective tissue. Unlike carcinomas, which start in the lining of organs or skin, sarcomas develop in the body’s structural framework.

These cancers are uncommon. They account for roughly 1 percent of all adult cancers. About 13,000 new cases are diagnosed in the United States each year. Because they are rare, they are often initially mistaken for benign lumps or bruises, which can delay proper evaluation.

Sarcoma can appear anywhere in the body. In adults, the most common locations are the arms, legs, and trunk. In children, sarcomas make up a larger share of cancer cases, but the disease still remains rare overall.

What Are the Symptoms of Soft Tissue Sarcoma?

The most common symptom is a painless lump that grows over time. Many people notice a swelling or mass that was not there before. The lump may be soft or firm to the touch. It is often movable under the skin, though deep tumors may feel fixed to surrounding tissue.

Pain is not typical in the early stages. When pain does occur, it usually means the tumor is pressing on a nerve, muscle, or bone. Some patients report a feeling of fullness or pressure in the affected area. If the tumor is in the abdomen, symptoms may include abdominal pain, bloating, or a feeling of early fullness when eating.

Other symptoms depend on location. A sarcoma near a joint may limit movement. One near a major blood vessel may cause swelling in the limb below the tumor. Neurological symptoms such as numbness or tingling can occur when nerves are involved.

There is one important point to remember: most soft tissue lumps are not cancer. Lipomas, which are benign fat tumors, are far more common than sarcomas. But any lump that is growing, is larger than about 2 inches, or is deep within a muscle should be evaluated by a doctor.

What Causes Soft Tissue Sarcoma?

Most soft tissue sarcomas have no identifiable cause. They appear to develop spontaneously from genetic errors in mesenchymal cells. These mutations are not inherited in the vast majority of cases.

Several risk factors are well established. Prior radiation therapy is one of the strongest. Patients who received radiation for other cancers have a slightly higher risk of developing sarcoma in the treated area, usually several years later. This is a rare complication of radiation, however, and the benefits of radiation for treating the original cancer almost always outweigh this risk.

Certain inherited genetic conditions increase risk. Li-Fraumeni syndrome, neurofibromatosis type 1, and familial adenomatous polyposis are all linked to higher sarcoma rates. These conditions are rare, and most sarcoma patients have none of them.

Exposure to certain chemicals, including vinyl chloride and dioxins, has been associated with sarcoma in some studies, but the evidence is not strong enough to establish a clear causal link. No dietary factor, exercise habit, or lifestyle choice has been proven to cause soft tissue sarcoma.

How Is Soft Tissue Sarcoma Diagnosed?

Imaging is the first step. An ultrasound, MRI, or CT scan can show the size, location, and depth of the mass. MRI is often preferred for limb tumors because it shows soft tissue detail clearly.

Imaging alone cannot confirm cancer. A biopsy is required. The most common method is a core needle biopsy, where a hollow needle removes a small cylinder of tissue. The sample is examined under a microscope by a pathologist who specializes in sarcoma. This is critical because the specific subtype of sarcoma affects treatment choices.

In some cases, the biopsy sample is also tested for genetic markers. Certain sarcomas have characteristic chromosomal translocations or gene mutations that help confirm the diagnosis and predict behavior. For example, synovial sarcoma has a specific translocation that is used for diagnosis.

Once sarcoma is confirmed, staging follows. A CT scan of the chest is standard to check whether the cancer has spread to the lungs, which is the most common site of metastasis. PET scans may be used in selected cases, but they are not required for every patient.

What Are the Treatment Options for Soft Tissue Sarcoma?

Surgery is the primary treatment for most localized sarcomas. The goal is to remove the entire tumor with a margin of normal tissue around it. This is called a wide local excision. When the tumor is in a limb, surgeons work to preserve the limb whenever possible. Amputation is now needed in fewer than 10 percent of cases.

Radiation therapy is often used alongside surgery. It may be given before surgery to shrink the tumor, or after surgery to kill any remaining microscopic cancer cells. Radiation reduces the risk of local recurrence, but it has not been shown to improve overall survival in most studies. It does carry side effects, including skin changes, fatigue, and long-term joint stiffness.

Chemotherapy is used in specific situations. For high-risk tumors, giving chemotherapy before or after surgery may reduce the chance of the cancer returning. The evidence for this benefit is strongest in certain subtypes, such as rhabdomyosarcoma and Ewing sarcoma, which are more common in children. For adult soft tissue sarcomas, the benefit is smaller and not all patients are candidates.

Targeted therapies are available for some subtypes. For example, imatinib is effective for gastrointestinal stromal tumors, a type of sarcoma that arises in the digestive tract. Other drugs target specific genetic mutations found in less common subtypes.

Immunotherapy has shown limited benefit in most sarcomas, though clinical trials are ongoing. Response rates have been low overall, and these drugs are not standard first-line treatment for most patients.

What Is the Prognosis for Soft Tissue Sarcoma?

Prognosis depends on several factors. The most important are the tumor’s size, grade, and whether it has spread. Grade refers to how abnormal the cells look under a microscope and how quickly they are likely to grow. Low-grade sarcomas grow slowly and have a better outlook. High-grade sarcomas are more aggressive.

For localized sarcomas that are completely removed with surgery, the five-year survival rate is roughly 80 percent. If the cancer has spread to distant organs, the five-year survival rate drops significantly, though some patients live much longer with treatment.

Local recurrence is a real concern. Even after successful surgery, sarcoma can return in the same area. This is why follow-up care is essential. Most patients are monitored with regular physical exams and imaging for at least five years after treatment.

It is important to understand that survival statistics are based on large groups of people. They cannot predict what will happen for any individual patient. Your oncologist can give you a more personalized estimate based on your specific tumor characteristics.

When Should You See a Doctor About a Lump?

Most lumps are harmless. But certain features should prompt a medical evaluation. See a doctor if a lump is growing, if it is larger than about 2 inches, or if it is deep within a muscle rather than just under the skin.

Pain, numbness, or weakness in the area of the lump also warrants evaluation. A lump that appears suddenly or changes in character should not be ignored.

Your doctor may refer you to an orthopedic oncologist or a surgical oncologist if sarcoma is suspected. These specialists have experience with rare tumors and can coordinate the appropriate imaging and biopsy.